ResearchShould CAR-T cell therapy be considered a standard of care for patients with refractory diffuse large B-cell lymphoma in second line treatment?
ResearchChimeric antigen receptor T cell therapy in octogenarians with B cell lymphoma: a real-world US multicenter collaborative study
ResearchFinal results of a multicentre pilot study evaluating brentuximab vedotin with cyclophosphamide, doxorubicin, etoposide and prednisone (BV-CHEP) for the treatment of aggressive adult T-cell leukaemia/lymphoma
ResearchPrognosis and Treatment of Plasmablastic Lymphoma in the United States: A Multicenter Retrospective Study
ResearchEpcoritamab monotherapy for Richter transformation (EPCORE CLL-1): findings from a single-arm, multicentre, open-label, phase 1b/2 trial
ResearchLong-term follow up of the combination of ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphocytic leukemia with biomarker analysis
ResearchHigh-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional series
ResearchLoncastuximab tesirine with rituximab in patients with relapsed or refractory follicular lymphoma: a single-centre, single-arm, phase 2 trial
ResearchOutcomes of follicular lymphoma with leukemic phase in the modern era: results from a large multicenter study
ResearchHigh-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study
ResearchPoor Outcome of Adult T-Cell Leukemia/Lymphoma with Current Available Therapy: An Experience of Two Centers
ResearchEfficacy of CD19 directed therapies in patients with relapsed or refractory large b-cell lymphoma relapsing after CD19 directed chimeric antigen receptor T-cell therapy
ResearchAn international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma